Literature DB >> 14693349

Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level.

P Gorwood1, J Pouchot, P Vinceneux, X Puéchal, R M Flipo, M De Bandt, J Adès.   

Abstract

There is wide evidence for a decreased risk of rheumatoid arthritis in patients with schizophrenia. Nevertheless, very few studies have looked at the risk of schizophrenia in a group of patients with rheumatoid arthritis. We prospectively investigated, with the SCL-90R, 220 consecutive outpatients with rheumatoid arthritis and 196 consecutive outpatients with various medical conditions, half of them suffering from psoriatic arthritis (a medical condition close to rheumatoid arthritis). The SCL-90R appears to be a valuable tool to distinguish patients with schizophrenia from the outpatients of our sample, the former having more "paranoid ideation" (p = 0.004) and more "psychoticism" (p < 0.001) than the latter. The "paranoid ideation" dimension was significantly lower (25% decrease) in the sample of patients with rheumatoid arthritis compared to the combined control group (p = 0.005), ratings under the median value being more frequent in the former group (p = 0.025). Confounding factors might not explain this difference according to the regression logistic analysis performed. As patients with rheumatoid arthritis have a lower score of paranoid ideation than controls in our sample, even after controlling for age, gender and severity of the disease, these data represent further evidence for a decreased risk of schizophrenia in individuals with rheumatoid arthritis.

Entities:  

Mesh:

Year:  2004        PMID: 14693349     DOI: 10.1016/s0920-9964(03)00017-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  17 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.

Authors:  John A Sturgeon; Patrick H Finan; Alex J Zautra
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

3.  Schizophrenia-like disorder associated with etanercept treatment.

Authors:  Onome Victor Atigari; David Healy
Journal:  BMJ Case Rep       Date:  2014-01-13

4.  Heritability and familiality of psychopathologic dimensions in Korean families with schizophrenia.

Authors:  Hwagyu Suh; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Soo Yeon Kim; Kang Yoon Lee; Young In Chung
Journal:  Psychiatry Clin Neurosci       Date:  2019-02-02       Impact factor: 5.188

5.  Transcriptome study of differential expression in schizophrenia.

Authors:  Alan R Sanders; Harald H H Göring; Jubao Duan; Eugene I Drigalenko; Winton Moy; Jessica Freda; Deli He; Jianxin Shi; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2013-07-30       Impact factor: 6.150

6.  Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis.

Authors:  A Kling; S Rantapää-Dahlqvist; H Stenlund; T Mjörndal
Journal:  Ann Rheum Dis       Date:  2006-06       Impact factor: 19.103

7.  High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis.

Authors:  Daniel R Studelska; Laura Mandik-Nayak; Xiaodong Zhou; Jing Pan; Peter Weiser; Lynda M McDowell; Hong Lu; Helen Liapis; Paul M Allen; Fei F Shih; Lijuan Zhang
Journal:  J Biol Chem       Date:  2008-10-22       Impact factor: 5.157

Review 8.  Dosage effects of human ribosomal genes (rDNA) in health and disease.

Authors:  L N Porokhovnik; N A Lyapunova
Journal:  Chromosome Res       Date:  2018-10-20       Impact factor: 5.239

9.  Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.

Authors:  Steven M Silverstein; Yushi Wang; Brian P Keane
Journal:  Front Psychol       Date:  2013-01-21

10.  RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia.

Authors:  Junzhe Xu; Jingchun Sun; Jingchun Chen; Lily Wang; Anna Li; Matthew Helm; Steven L Dubovsky; Silviu-Alin Bacanu; Zhongming Zhao; Xiangning Chen
Journal:  BMC Genomics       Date:  2012-12-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.